[Trimethoprim-sulphamethoxazole (septrin) for therapy of long-term carriers of typhoid bacteria. Preliminary report].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013997:Time Factors; D014295:Trimethoprim / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Trimethoprim-sulphamethoxazole (Septrin) zur Sanierung der Typhusbakteriendauerausscheider. Vorläufige Mitteilung.